US OptionsDetailed Quotes
VCYT241220P45000
- 0.00
- 0.000.00%
15min DelayClose Dec 2 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest45.00Strike Price0.00Turnover58.57%IV-1.99%PremiumDec 20, 2024Expiry Date0.88Intrinsic Value100Multiplier18DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5291Delta0.0696Gamma16.19Leverage Ratio-0.0615Theta-0.0114Rho-8.57Eff Leverage0.0390Vega
Veracyte Stock Discussion
Sign in to post a comment
Cathie Wood and Ark Invest's trade activity from today 9/10
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...
2
Analysts are slightly more optimistic about Veracyte's losses per share, but expect its revenue growth to slow down substantially compared to its historical 29% growth rate. The wider industry is expected to outpace Veracyte.
1
The absence of any insider transactions in the past three months doesn't reveal much. Low insider ownership and previous insider selling at Veracyte sparks less enthusiasm. Investors should be aware of potential risks associated with the company.
Gapping up
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
10
1
Gainers:
• $Theravance Biopharma (TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma (AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners (GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy (TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
• $Theravance Biopharma (TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma (AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners (GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy (TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
10
1
5
Gainers:
• $Microvast (MVST.US)$ +14.6% (In reaction to earnings)
• $Sea (SE.US)$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $JD.com (JD.US)$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase (COIN.US)$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen (HLGN.US)$ +5%(to restate Full Year 2021 Financials)
• $Take-Two Interactive Software (TTWO.US)$ +4.9% (de...
• $Microvast (MVST.US)$ +14.6% (In reaction to earnings)
• $Sea (SE.US)$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $JD.com (JD.US)$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase (COIN.US)$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen (HLGN.US)$ +5%(to restate Full Year 2021 Financials)
• $Take-Two Interactive Software (TTWO.US)$ +4.9% (de...
21
2
6
Gainers：
• $Affirm Holdings (AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood (HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group (EDR.US)$ +20% (in reaction to earnings)
• $Coinbase (COIN.US)$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies (DVAX.US)$ +11.5% (to join ...
• $Affirm Holdings (AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood (HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group (EDR.US)$ +20% (in reaction to earnings)
• $Coinbase (COIN.US)$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies (DVAX.US)$ +11.5% (to join ...
27
2
16
ETFs managed by Cathie Wood's ArkInvestment Management bought 363,261 shares of Robinhood Markets.
ARK's buys
$Robinhood (HOOD.US)$ $Nu Holdings (NU.US)$ $Veracyte (VCYT.US)$ $Personalis (PSNL.US)$ $PagerDuty (PD.US)$ $Quantum-Si (QSI.US)$
ARK's sells
$Iovance Biotherapeutics (IOVA.US)$ $LivePerson (LPSN.US)$ $3D Systems (DDD.US)$
ARK's buys
$Robinhood (HOOD.US)$ $Nu Holdings (NU.US)$ $Veracyte (VCYT.US)$ $Personalis (PSNL.US)$ $PagerDuty (PD.US)$ $Quantum-Si (QSI.US)$
ARK's sells
$Iovance Biotherapeutics (IOVA.US)$ $LivePerson (LPSN.US)$ $3D Systems (DDD.US)$
4
4
more... There's nothing wrong with digging the bottom. . ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
No comment yet
Bigmoney Dreamer : in33$
40$+ 